Not Yet RecruitingPhase 4ketamine

Ketamine in Central Sensitization

Sponsored by University Hospitals Cleveland Medical Center

NCT ID
NCT07182032
Target Enrollment
126 participants
Start Date
2026-02-01
Est. Completion
2028-06-30

About This Study

The purpose of this research study is to see if ketamine infusion during surgery can decrease pain after surgery. Ketamine is a medication commonly used as part of anesthesia during surgery and is approved by the US FDA. Patients will be randomized to either receive standard anesthesia with OR without ketamine. The surgical procedure will be the same regardless of which group patients are randomized to. After surgery, patients will be asked to rate their pain in the post-operative observation unit and at their two-week post-operative visit. No additional visits are required for participation in this study. The investigators estimate the surveys will take approximately 10 minutes to complete.

Conditions Studied

EndometriosisChronic Pelvic Pain

Interventions

  • ketamine

Eligibility

Sex:FEMALE
Age:18 Years - 89 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* age range 18-89
* ASA classification I-III
* outpatient elective laparoscopy for endometriosis

Exclusion Criteria:

* known allergy or contraindication to ketamine
* History of substance use disorder, including alcohol or marijuana use, both current and remote
* History of severe psychiatric illness, including schizoaffective disorder, bipolar disorder, psychosis, or decompensated psychiatric condition , excluding anxiety and depression
* Current Intraoperative complications

Study Locations (1)

University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source